Back to top

RELEASE AND SETTLEMENT AGREEMENT

Settlement Agreement

RELEASE AND SETTLEMENT AGREEMENT | Document Parties: MEDICAL DISCOVERIES INC | JUDY M. ROBINETT You are currently viewing:
This Settlement Agreement involves

MEDICAL DISCOVERIES INC | JUDY M. ROBINETT

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: RELEASE AND SETTLEMENT AGREEMENT
Date: 9/17/2007
Industry: Biotechnology and Drugs     Sector: Healthcare

RELEASE AND SETTLEMENT AGREEMENT, Parties: medical discoveries inc , judy m. robinett
50 of the Top 250 law firms use our Products every day

Exhibit 10.4
 
RELEASE AND SETTLEMENT AGREEMENT
 
THIS RELEASE AND SETTLEMENT AGREEMENT (this “Agreement”) is entered into by and between JUDY M. ROBINETT, an individual (“Robinett”) and MEDICAL DISCOVERIES, INC., a Utah corporation (hereinafter referred to as “MDI”) on the following premises:

Premises

A .   On or about April 1, 2005, Robinett and MDI entered into an employment agreement (the “Employment Agreement”).

B.   As of March 31, 2007, under the terms of the Employment Agreement, MDI owed Robinett approximately $1,851,804.93 in accrued and unpaid compensation, un-accrued and pro-rata bonuses, and severance pay.

C.   The parties have raised issues respecting the amount due to Robinett and MDI’s ability to pay such amount and desire to reach an agreement resolving such issues in order to facilitate anticipated financing for MDI. Accordingly, Robinett has agreed to accept in settlement of the amount owed a sum of $500,000.00, payable from proceeds from the sale of certain Formestane assets owned by MDI (the “Formestane Asset Sale”) to Eucodis, a third party.

D.   The parties desire to enter into a full and complete release and settlement with each other, compromising, resolving, and settling all matters between them and buying peace.

Agreement

NOW, THEREFORE, upon these premises, which are incorporated herein by reference, and for and in consideration of the mutual promises and covenants set forth herein and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, it is hereby agreed as follows:

1.   Payment to Robinett . MDI agrees to pay Robinett the sum of $500,000, following MDI’s closing of the Formestane Asset Sale and its receipt of the payment for such sale, subject to Robinett fulfilling the “Ongoing Duties” set forth in Section 5 herein. Robinett agrees that, with the exception of the payment described in this Section 1 and the compensation payable pursuant to Sections 5 and 6 hereof, she will not be owed any amounts by MDI under the Employment Agreement or otherwise for her services as an employee, director or consultant of MDI through the date of her resignation pursuant to Section 7, whether in the form of salary, bonus, vacation pay, sick pay or any other compensation or benefits, and MDI shall have no other obligation to provide or maintain any compensation or benefits for MDI after the date of her deemed resignation.

2.   Timely Disbursal of Funds . In order to facilitate the timely transfer of funds on the closing of the Formestane Asset Sale, including MDI’s receipt of at least $2,000,000 in cash (the “Formestane Closing”), Five Hundred Thousand dollars ($500,000.00) from the Formestane Closing shall be held in the Emmes Group’s Client Trust account, and shall be disbursed to Robinett upon the fulfillment of the “Ongoing Duties” set forth in Section 5 herein. Such disbursal shall be affected by wire transfer of funds to such bank account or accounts as Robinette may specify to the Emmes Group in writing. In order to implement the foregoing, contemporaneously with the execution of this Agreement the parties shall execute and deliver to the Emmes Group the parties’ irrevocable disbursal instructions in the form attached hereto as Exhibit A and incorporated herein by reference.
 
1

 
3.   Waiver of 2007 Bonus . Robinett waives any pro rata 2007 bonus, otherwise granted at the discretion of MDI’s Board of Directors.

4.   Stock Options . Robinett shall retain her previously granted incentive stock options to purchase two million (2,000,000) shares of MDI common stock (the “Retained Options”) (subject to stock splits, stock dividends, and similar pro rata adjustments). The Retained Options shall continue to have the same terms and conditions as currently in existence, including an option price of $0.01 per share, and the 5:00PM Pacific Time, December 31, 2012 expiration date. All other incentive stock options awarded Robinett during her tenure with MDI shall be cancelled.

5.   Ongoing Duties . Robinett shall continue to act as Chief Executive Officer of MDI at an annual salary of $250,000 per year for a period commencing April 1, 2007, and terminating upon the completion of MDI’s financial audit and the completion, signing, and filing of the officer certifications to be attached as exhibits to the Form 10-KSB for 2006 and the Forms 10-QSB for 2007. During such period, and provided MDI receives interim enabling financing, Robinett’s primary responsibilities shall include using her commercially reasonable best efforts to:

(a)   Cause MDI to file all delinquent periodic reports required to be filed by it pursuant to sections 13 or 15(d) under the Securities Exchange Act of 1934;

(b)   Manage MDI’s 2006 audit, which duties include completing, signing, and filing the officer certifications to be attached as exhibits to the Form 10-KSB for 2006 and the Forms 10-QSB for 2007 ;

(c)   Complete the sale of the Formestane asset to Eucodis Pharmaceuticals Forschungs - und Entwicklungs GmbH;

(d)   Manage, provide support, or personally conduct negotiations with all MDI creditors not transferred to Eucodis, with the objective of achieving a level of reduction in the remaining debt of MDI satisfactory to MDI’s Chairman of the board of directors;

(e)   Seek and obtain written approval from the Chairman of the MDI Board prior to the release and payment of any MDI funds; and,

(f)   Coordinate the delivery of all MDI company records to a location directed by the Chairman of the MDI Board.

6.   Sale of MDI-P Asset . MDI shall pay Robinett 15% of all consideration passing to MDI for the sale or transfer of MDI’s MDI-P asset in cash or in kind, payable if, as and when received.

7.   Robinett’s Resignation . Upon the completion of MDI’s financial audit, and the completion, signing, and filing of the officer certifications to be attached as exhibits to the Form 10-KSB for 2006 and the last of the Forms 10-QSB for 2007, Robinett shall automatically be deemed to have resigned as an officer, director, and employee of MDI.

8.   Release of Claims and Waiver by Robinett . Upon Robinett’s resignation as an officer, director and employee of MDI and expressly subject thereto, Robinett, for herself and for her present and former employees, agents, attorneys, heirs, administrators, personal representatives, successors, and assigns, shall be deemed to have irrevocably released, remised, acquitted, and forever discharged and agreed to indemnify MDI, including all of its future, present, and former employees, agents, representatives, consultants, attorneys, fiduciaries, servants, officers, directors, managers, partners, predecessors, successors and assigns, subsidiary and parent entities, from any and all actions and causes of action, judgments, execution, suits, debts, claims, demands, liabilities, obligations, damages, and expenses of any and every character, known or unknown, direct and/or indirect, at law or in equity, or whatsoever kind or nature, arising prior to the date hereof, for or because of any matter or things done, omitted, or suffered to be done by any of the other parties prior to and including the date of execution hereof, and in any way directly or indirectly arising out of or in any way connected therewith, save and except only any obligation or covenant arising under this Agreement. Robinett acknowledges that the agreements in this paragraph are intended to be in full satisfaction of any and all related injuries or damages arising prior to the date hereof in connection with her relationship with MDI.
 
2

 
9.   Release of Claims by MDI . Except in the event of the discovery of fraud or other such willful misconduct on the part of Robinett, upon Robinett’s resignation as an officer, director and employee of MDI of MDI and expressly subject thereto, MDI, for itself and its present and former officers, shareholders, directors, managers, members, employees, agents, attorneys, heirs, administrators, personal representatives, successors, and assigns, shall be deemed to have irrevocably released, remised, acquitted, and forever discharged, and agreed to indemnify and hold harmless Robinett, together with all of her future, present, and former agents, representatives, consultants, attorneys, fiduciaries, servants, partners, predecessors, successors, and assigns, from any and all actions and causes of action, judgments, executions, suits, debts, claims, demands, liabilities, obligations, damages, and expenses of any and every character, known or unknown, direct and/or indirect, at law or in equity, of whatsoever kind or nature arising prior to and as of the date hereof, for or because of any matter or thing done, omitted, or suffered to be done by any of the other parties prior to and including the date of execution hereof, and in any way directly or indirectly arising out of or in any way connected with claims by or against Robinett, save and except only any obligation or covenant arising under this Agreement. MDI acknowledges that the agreements in this paragraph are intended to be in full satisfaction of any and all related injuries or damages arising prior to the date hereof in connection its relationship with Robinett.

10.   Robinett Covenant Not To Sue . Upon Robinett’s resignation as an officer, director and employee of MDI and expressly subject thereto, Robinett hereby covenants and agrees that she will not at any time, directly or indirectly, initiate, maintain, or prosecute, or in any way knowingly aid in the initiation, maintenance, or prosecution, of any claim, demand, or cause of action, at law, in equity, or otherwise, against MDI, including all of its future, present, and former employees, agents, representatives, consultants, attorneys, fiduciaries, servants, officers, directors, managers, partners, predecessors, successors and assigns, subsidiary corporations and companies, and parent corporations and companies for any claim, damage, loss, or injury of any kind arising out of or in an

 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more